Catalyst Repository | CNS Pharmaceuticals Inc. Common Stock

CNS Pharmaceuticals Inc. Common Stock

(NASDAQ:CNSP)

Description

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas.

CNSP Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$2.3300
Previous Close Volume
63110


Latest News